Skip to content
Log in
Sponsored AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI

Author

M. Marinho

h-index 6 View on Semantic Scholar

We have 4 of 36 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Coumarin‐Benzimidazole Hybrids as Multitarget Scaffolds for Antileishmanial Drug Discovery

Leishmaniasis is a globally distributed zoonosis and a major challenge to public health, with increasing incidence and limited therapeutic options marked by toxicity and emerging resistance. Aiming to identify safer and more effective alternatives for disease control, this study evaluated the antileishmanial potent...

Fernanda Melo Jucá, Damião Sampaio de Sousa, Caio Henrique Alexandre Roberto et al. · 0 citations
Jul 2026

Structural insights into the structure-activity relationships of flavonoids targeting WSSV and LvGSTMu.

Results suggest that flavonoids, particularly amentoflavone, represent promising scaffolds for the development of antiviral and antioxidant agents against WSSV, warranting further experimental validation.

Damião Sampaio de Sousa, João Miguel Lopes de Melo Lima, Jacilene Silva et al. · 0 citations
Open access Aug 2026

Mapping the electronic and biological landscape of halogenated aryl quinoline derivatives via computational approaches

The results showed that the QNL1 and QNL3 derivatives were the most favorable due to high intestinal absorption and apparent permeability and apparent permeability, showing potential as a future drug.

M. Sales, Caroline Do Nascimento Gonçalves, Abraão Lucas Silva dos Santos et al. · 0 citations
Open access Jul 2026

Evaluation of Chalcone (E)‑3-(4-Fluorophenyl)-1-(2-hydroxy-3,4,6-trimethoxyphenyl)-prop-2-en-1-one against Trypanosoma cruzi (Y Strain): In Vitro Assay, In Silico Drug-Target Analysis, and MPO-Based Drug Likeness

The CPN4F molecule demonstrates potent in vitro efficacy against Chagas disease, outperforming BZN in molecular docking studies targeting cruzain and outperforming BZN in molecular docking studies targeting cruzain.

J. Pinto, Francisco Nithael Melo Lucio, L. R. Ribeiro et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.